Fig. 1
- ID
- ZDB-FIG-220701-31
- Publication
- Tucker et al., 2021 - Development and biological characterization of a clinical gene transfer vector for the treatment of MAK-associated retinitis pigmentosa
- Other Figures
- All Figure Page
- Back to All Figure Page
Design and generation of MAK gene transfer constructs.
A Schematic depicting the four AAV constructs generated in this study. Constructs were designed to deliver either the human canonical (MAKCI - lacks exon 12, constructs 1 and 3) or retina-specific MAK isoform (MAKRI - contains exon 12, constructs 2 and 4) under control of either the constitutively active CMV or EF1? promoter. B Representative image of cultured murine JK1 cells (immortalized SMA?+?, CD34?+?testicular stromal cells, which lack endogenous expression of human MAK). Scale bar?100??m. C, D rt-PCR analysis performed on RNA isolated from JK1 cells transduced with either AAV5-CMV-MAKCI (Construct 1), AAV5-CMV-MAKRI (Construct 2), AAV5-EF1?-MAKCI (Construct 3), or AAV5-EF1?-MAKRI (Construct 4). Each construct is capable of driving robust expression of exon-9-containing human MAK transcript (C). Unlike the MAKCI constructs, both AAV5-CMV-MAKRI and AAV5-EF1?-MAKRI constructs are capable of driving expression of the exon-12-containing retina-specific MAK transcript (D). Arrows denote rt-PCR primer positions. |